Ring-fence a fifth of national cancer research money for metastasis
Spread causes around nine in ten cancer deaths but receives a small slice of research funding. A funding floor would change what gets studied.
Portfolio analyses have repeatedly put metastasis research at roughly 5-10% of cancer research spend. A committed floor — with a transparent classification method, an annual public report and a dedicated review panel that understands metastasis models — is a pure policy lever with no scientific risk, only allocation risk.
- Metastasis is understood least and studied last · Metastasis causes about nine in ten cancer deaths but gets a small fraction of research money and almost no trials of its own.
- Funding follows fashion, not burden · Money goes to the cancers and questions that are easy or popular, not the ones that kill most or where a dollar would do most.
Pages like this
not linked directly; found by shared links- IdeaPublish per-patient trial cost benchmarks and target halving them
Shares Funding follows fashion, not burden, Cancer Research UK, National Cancer Institute (NIH).
- IdeaA public registry of unanswered clinical questions linked to funding calls
Shares Funding follows fashion, not burden, Cancer Research UK, National Cancer Institute (NIH).
- IdeaA dedicated global financing window for cancer, modelled on the Global Fund
Shares GLOBOCAN / Global Cancer Observatory, Funding follows fashion, not burden.
- InstitutionWorldwide Cancer Research
Shares Funding follows fashion, not burden, Cancer Research UK.
- IdeaRandomised trials of how to spread proven cancer treatments, not just what works
Shares Funding follows fashion, not burden, National Cancer Institute (NIH).
- IdeaJudge funding programme officers on burden alignment and trials completed
Shares Funding follows fashion, not burden, Cancer Research UK, National Cancer Institute (NIH).
- IdeaDisclose R&D and manufacturing costs of publicly funded cancer drugs to get coverage
- IdeaMandatory machine-readable portfolio reporting for all large cancer funders
Shares Funding follows fashion, not burden, Cancer Research UK, National Cancer Institute (NIH).